In a recent study published in Med, researchers monitored the remarkably rapid Omicron BA.1 to BA.2 sublineage dominance transition in the Swedish population in early 2022 on a day-to-day basis using ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of an RT-PCR kit that allows researchers to simultaneously screen samples for Zika (ZIKV), dengue (DENV1, DENV2, DENV3, DENV4 ...

The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has highlighted concerns involving semen samples for cryobanking. Study: Validation of a SARS-CoV-2 RT-PCR ...

LUXEMBOURG--(BUSINESS WIRE)--The GSD NovaPrime® SARS-CoV-2 Direct RT-PCR is intended for the qualitative detection of SARS-CoV-2 from human nasopharyngeal swabs, eluted directly into deionised water ...

A One-Step RT-qPCR assay based on the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel has been developed which can effectively detect SARS-CoV-2 particles from saliva samples ...

Surrogate role of kinetic of perioperative circulating cancer cells (CTCs) in patients with liver metastases (M) of colorectal cancer (CRC). Value of circulating epithelial tumor cells and circulating ...

The Reliance SARS-CoV-2 RT-PCR Kit is a real-time reverse-transcription PCR (RT-PCR) test that can detect nucleic acid in SARS-CoV-2, the virus associated with COVID-19 disease. A version of the assay ...

No Published Viral Mutations to Date, Including Omicron Variant, Meaningfully Impact the Regions of the Viral Genome Targeted by the Assay SOUTH SAN FRANCISCO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) - ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component.

Real-time PCR has gained significant acceptance by high-complexity clinical laboratories developing tests for a variety of applications. Sensitivity, automation, and turnaround time have made PCR ...

Recurrent disease develops in up to 35% of patients treated for seemingly confined colorectal cancer. It is likely that these patients had micrometastases that were not detected at the time of staging ...